(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This book is a practical guide on how best to incorporate advanced radiation therapy techniques into the multimodality treatment of a wide range of gastrointestinal tumors, including esophageal cancer, gastric cancer, hepatobiliary malignancies (primary and metastatic liver tumors, intrahepatic, perihilar, and extrahepatic cholangiocarcinomas, and gallbladder cancer), pancreatic cancer, colorectal cancer, and carcinoma of the anal canal. Practical considerations when treating patients with external beam radiation therapy, intensity-modulated radiation therapy, particle therapy, and stereotactic body radiation therapy are clearly explained. Detailed attention is devoted to the safety and efficacy of radiotherapy in combination with current and emerging systemic therapies (chemotherapy, immunotherapy, and biologic agents), surgery, and ablative therapy, and the advantages and disadvantages of alternative treatment approaches for different tumor types are carefully evaluated. The book will benefit radiation oncologists, medical and surgical oncologists, medical physicists, medical dosimetrists, and other oncology professionals.
Contents:
PART I: Esophageal Cancer
1. Proximal/Cervical Esophageal Cancer
2. Mid/Distal Esophageal Cancer
3. Gastroesophageal Junction Cancers
PART II: Gastric Cancer/Siewert Type III
4. Neoadjuvant Radiation Approaches
5. Adjuvant Radiation
PART III: Hepatobiliary Malignancies
6. Hepatocellular Carcinoma
7. Liver Metastases (secondary tumors of the liver)
8. Intrahepatic Cholangiocarcinoma
9. Perihilar Cholangiocarcinoma
10. Extrahepatic Cholangiocarcinoma
11. Gall Bladder Cancer
PART IV: Pancreatic Cancer
12. Resectable
13. Borderline resectable
14. Locally advanced
PART V: Colorectal Cancer
15. Colon Cancer: Indications for adjuvant therapy
16. Rectal Cancer
17. Liver Metastases (include just CRC mets separately in this section and all other mets in section 3B above)
18. Role of pelvic RT in the metastatic setting: this section could highlight how to incorporate RT when there are liver mets and you need to consider systemic control as well as pelvic control
PART VI: Carcinoma of the Anal Canal
PRODUCT DETAILS
Publisher: Springer (Springer International Publishing AG)
Publication date: January, 2018
Pages: None
Weight: 789g
Availability: Available
Subcategories: Gastroenterology, Oncology